Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Selemycin 100mg/2ml solution for injection/ infusion.
Selemycin 250mg/2ml solution for injection/infusion.
Selemycin 500mg/2ml solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection/infusion. Clear colourless to slightly yellow solution. |
Each vial/ampoule contains amikacin 100mg, 250 mg or 500mg as amikacin sulphate.
Excipient(s) with known effect: sodium metabisulphite and sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amikacin |
Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins. |
| List of Excipients |
|---|
|
Sodium citrate dihydrate |
Selemycin 100mg/2ml:
Type I clear glass ampoules of 2ml filling capacity in packs of 10 and 100 ampoules.
Selemycin 250mg/2ml and Selemycin 500mg/2ml:
Type I clear glass vials of 5ml nominal capacity vial, sealed with a grey bromobutyl rubber stopper with an aluminium over cap in packs of 1, 10, 50 or 100 vials.
Type I clear glass ampoules of 2ml filling capacity in packs of 10 and 100 ampoules.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Selemycin 100mg/2ml: 21944
Selemycin 250mg/2ml: 19896
Selemycin 500mg/2ml: 19897
Selemycin 100mg/2ml: 15/10/2013 / 13/11/2019
Selemycin 250mg/2ml: 28.12.2005 / 10.06.2011
Selemycin 500mg/2ml: 28.12.2005 / 14.09.2011
| Drug | Countries | |
|---|---|---|
| SELEMYCIN | Cyprus, Estonia, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
